We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App




Urine Sample Collection Tubes Relaunched for Microbial Diagnostics

By LabMedica International staff writers
Posted on 02 Dec 2015
A next-generation urine sample collection tube contains an innovative additive that effectively stabilizes bacterial count for up to 48 hours at room temperature, enabling more reliable clinical diagnosis and research.

The medical threshold for diagnosing a urinary tract infection (UTI) is ≥105 CFU/mL. More...
Accurate determination of bacteria count at or very near urine sampling is critical for correct diagnosis. However, rapid bacterial growth in urine samples can lead to false positive results, which would lead to patients taking antibiotics unnecessarily.

The new VACUETTE Urine CCM tube from Greiner Bio-One International GmbH (Kremsmünster, Austria) was introduced in 2014 and is now being relaunched as particularly suitable for microbiological diagnostics and research. The tube contains a highly soluble powder that quickly impedes bacterial growth upon simple thorough mixing with urine sample via only a few inversions of the tube. The sample remains stable with no need for refrigeration – up to 48 hours when stored at 20–25 °C.

Another advantage of the VACUETTE Urine CCM tube is its easy-to-open safety cap that allows for hygienic opening and working conditions – without risk of splashes as may occur with standard rubber stoppers. Plus, the tube is shatterproof and made from highly transparent PET plastic.

A large number of obligatory and optional pathogenic urogenital bacteria can be stabilized in the VACUETTE Urine CCM tube for reliable detection up to 48 hours. UTIs are most commonly caused by Escherichia coli or Staphylococcus spp. In addition to these two bacteria, internal GBO studies have verified the stabilization of Salmonella enteritidis, Candida albicans, and Enterococcus faecalis, and that even certain sensitive microorganisms, such as Streptococcus spp., are stabilized sufficiently.

Related Links:

Greiner Bio-One International GmbH



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.